GlassScriptPhysician profile
Corey Jones
NPI 1578025052
$19,834.88
in general payments reported to CMS, 2019-2025
9 companies · $9,190 in 2025
The $9,190 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $25.77 · 2024: $11K · 2025: $9,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $8,750 · Travel and Lodging: $5,687 · Food and Beverage: $5,351 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $8,750.00 |
| Travel and Lodging | $5,687.13 |
| Food and Beverage | $5,350.97 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11,626.10 | 2024-2025 | Journey II, Real Intelligence, Legion Revision |
| Zimmer Biomet Holdings, INC. | $5,042.01 | 2024-2025 | Arcos, Persona, Avenir |
| Stryker Corporation | $2,433.63 | 2024-2025 | Mako, T2 Alpha, Biolox |
| Depuy Synthes Sales INC. | $299.02 | 2024-2025 | Na, Va-Lcp |
| Orthalign INC | $158.73 | 2024 | Orthalign Plus |
| Bone Support INC. | $158.21 | 2024 | Cerament G, Ceramentbone Void Filler |
| Medtronic, INC. | $71.87 | 2023-2024 | Aquamantys(Tm) |
| Restor3d, INC. | $24.61 | 2024 | |
| Solventum Corporation | $20.70 | 2024 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.